Functional Impairment, Healthcare Costs and the Prevalence of Institutionalisation in Patients with Alzheimer's Disease and Other Dementias

Author： Hill Jerrold  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.3, 2006-01, pp. : 265-280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of Alzheimer's Disease and Other Dementias

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 33, Iss. 2, 2003-06 ,pp. : 138-143

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alzheimer’s disease and related dementias:

By Williams M.   Davis R.E.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 6, 1997-06 ,pp. : 735-759

Informa Healthcare

Access to resources Recommend Favorite

Dementia: functional impairment drives up costs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 500, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Costs of a Community Pharmacist-Led Medicines Management Service for Patients with Coronary Heart Disease in England: Healthcare System and Patient Perspectives

By Scott Anthony   Tinelli Michela   Bond Christine  

PharmacoEconomics, Vol. 25, Iss. 5, 2007-01 ,pp. : 397-411

Adis International

Access to resources Recommend Favorite

Healthcare Costs and Obesity Prevention: Drug Costs and Other Sector-Specific Consequences

By Rappange David R.  

PharmacoEconomics, Vol. 27, Iss. 12, 2009-12 ,pp. : 1031-1044

Adis International

Access to resources Recommend Favorite